top of page
Kinase Inhibition and Nanotechnology for Diabetes research
- the best kind!
Kinase
Inhibition and
Nanotechnology for
Diabetes
research group
Welcome!
The KIND group was established with the focus to understand the fundamental properties of kinase inhibitors, its effective nano-delivery and stem cell activation to regenerate the damaged pancreas to treat Diabetes.
We are located within the X-Ray Crystallography Laboratory at the Malopolska Centre of Biotechnology at the Jagiellonian University in Krakow, Poland.
Research
Novel approaches for diabetes management by combination of
kinase inhibition and stem cells application
Restoration of beta-cell function via inhibition of diabetic kinome
Protein Crystallography
Nanotechnology
Stem Cells
bottom of page